Concurrent Reports First Quarter Fiscal Year 2017 Financial Results
Nov 09, 2016 21:01 pm UTC| Business
ATLANTA, Nov. 09, 2016 -- Concurrent (NASDAQ:CCUR), a global provider of high-performance Linux® and storage solutions, today announced financial results for the first quarter ended September 30, 2016. “In the first...
Coherus BioSciences Reports Third Quarter 2016 Operating and Financial Results
Nov 09, 2016 21:01 pm UTC| Business
REDWOOD CITY, Calif., Nov. 09, 2016 -- Coherus BioSciences, Inc. (Nasdaq:CHRS), today reported financial results and reviewed corporate events for the third quarter ended September 30, 2016. Corporate Highlights for...
Nuvectra Reports Third Quarter 2016 Financial Results
Nov 09, 2016 21:01 pm UTC| Business
PLANO, Texas, Nov. 09, 2016 -- Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical device company, announced today financial results for the third quarter ended September 30, 2016. Highlights U.S. Algovita...
Invuity to Present at Upcoming Conferences
Nov 09, 2016 21:01 pm UTC| Business
SAN FRANCISCO, Nov. 09, 2016 -- Invuity, Inc. (NASDAQ:IVTY), a leading surgical photonics company, today announced that company management is scheduled to present at the following upcoming investor conferences: The...
TPI Composites, Inc. Announces Third Quarter 2016 Earnings Results
Nov 09, 2016 21:01 pm UTC| Business
SCOTTSDALE, Ariz., Nov. 09, 2016 -- TPI Composites, Inc. (Nasdaq:TPIC), the largest U.S.-based independent manufacturer of composite wind blades, today reported financial results for the quarter ended September 30,...
Chemical Financial Corporation Announces Fourth Quarter Cash Dividend
Nov 09, 2016 21:01 pm UTC| Business
MIDLAND, Mich., Nov. 09, 2016 -- Chemical Financial Corporation (NASDAQ:CHFC) today announced that the Board of Directors of the Corporation declared a fourth quarter 2016 cash dividend on its common stock of $0.27 per...
Aviragen Therapeutics to Present at Stifel 2016 Healthcare Conference
Nov 09, 2016 21:01 pm UTC| Business
ATLANTA, Nov. 09, 2016 -- Aviragen Therapeutics, Inc.(NASDAQ:AVIR), a pharmaceutical company that is developing the next generation of antivirals, today announced that Aviragen’s CFO Executive Vice President Mark...